TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.

Deborah A Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.